![\"\"](\".\/media_10a98dee7038f215d8f12e46eb0a3b1649f0f9677.jpg?width=750&format=jpg&optimize=medium\")
<\/p>\nImage<\/p>\n
<\/p>\n
Image Credit<\/p>\n
Roberto Pfeil \/ Picture Alliance \/ Contributor via Getty Images)<\/p>\n
Image Alt<\/p>\n
31 January 2025, North Rhine-Westphalia, Leverkusen: ILLUSTRATION – A man holds a syringe with the drug Ozempic for the treatment of type 2 diabetes.<\/p>\n
Image Size<\/p>\n
landscape-medium<\/p>\n
Key Takeaways<\/p>\n
Nearly 2,000 lawsuits allege Ozempic caused health issues including stomach paralysis and vision loss.
\n Celebrity endorsements and off-label use have fueled the drug\u2019s popularity beyond diabetes treatment.
\n Legal proceedings are underway, with early trials expected in 2026 and potential damages exceeding $2 billion.<\/p>\n
Ozempic<\/a>, a drug approved for type 2 diabetes but widely used for weight loss, is now at the center of one of the biggest pharmaceutical lawsuits in recent years. According to Financial Express<\/a>, nearly 2,000 lawsuits have already been filed in U.S. courts, with potential damages topping $2 billion as of Monday (Aug. 18).<\/p>\n The medication, made by Novo Nordisk, belongs to a class of drugs known as GLP-1 receptor agonists. It works by suppressing appetite and regulating blood sugar, which is why it surged in popularity for weight loss. But patients say the benefits came with life-altering consequences.<\/p>\n Court filings cite severe side effects, including gastroparesis (stomach paralysis), intestinal blockages, persistent vomiting, gallbladder issues, pancreatitis, kidney damage<\/a>, and sudden vision loss linked to a condition called NAION. Financial Express reported that patients are blaming the drug for these health issues and “other severe complications not clearly warned about.”<\/p>\n Novo Nordisk has denied wrongdoing, saying Ozempic is safe when used as prescribed and that all drugs carry risks. Still, the lawsuits argue the company failed to fully disclose dangers, especially as Ozempic became a go-to weight loss option for people without diabetes. The first lawsuit was filed in August 2023, and by February 2024, the cases were consolidated into multidistrict litigation in Pennsylvania. As of May 2025, more than 1,800 cases remain pending, with early trials expected in 2026.<\/p>\n Hollywood\u2019s Ozempic obsession<\/p>\n While the legal fight plays out, Ozempic has also made headlines in Hollywood. Fat Joe<\/a> admitted to<\/a> using it after years of weight struggles, Tracy Morgan revealed on \u201cToday with Hoda & Jenna<\/a>\u201d in 2023 that it helped him shed pounds, and Kandi Burruss said<\/a> she tried it but saw no results. Macy Gray, one of the only celebs to express adverse effects, shared on MTV\u2019s \u201cThe Surreal Life\u201d that the drug left her with painful constipation.<\/p>\n